Remove Drug Delivery Remove Drugs Remove Insulin
article thumbnail

Biotts claims a first with insulin delivery across skin

pharmaphorum

Polish drug delivery company Biotts says it has demonstrated delivery of insulin across the skin for the first time without the use of an injection system.

Insulin 115
article thumbnail

Novo Nordisk once-weekly insulin clears first phase 3 test

pharmaphorum

For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying to change that. cases of hypoglycaemia per year with insulin icodec, versus 0.27 events for the once-daily drug. In absolute terms, there were 0.73

Insulin 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Droplet Micron Insulin Needle Offers Innovation in Crowded Diabetes Supply Market

XTalks

Being hailed as the world’s shortest and thinnest needle for insulin injection, Droplet Micron has recently been introduced into the pen needle market by HTL (High Tech Lab)-STREFA, Inc. These are important feature innovations for those that depend on insulin injections. The new and innovative needle measures at just 34G x 3.5mm.

Insulin 98
article thumbnail

Oramed inks deal to commercialize oral insulin in South Korea

BioPharma Reporter

Oramed Pharmaceuticals, a company focused on the development of oral drug delivery platforms, has signed an exclusive commercial distribution agreement for the Republic of Korea with local player, Medicox Co Ltd, in relation to its oral insulin candidate.

Insulin 77
article thumbnail

Eli Lilly Partners with Amazon Pharmacy for Home Delivery of Drugs

XTalks

LillyDirect Pharmacy Solutions, Eli Lilly’s direct-to-consumer (DTC) drugs website, is teaming up with Amazon Pharmacy to deliver select medications to people’s homes. The drugs include Lilly’s newly approved GLP-1 obesity drug Zepbound (tirzepatide), around a dozen of the company’s insulins and migraine drug Emgality (galcanezumab).

Pharmacy 111
article thumbnail

In the News: September Regulatory and Development Updates

Camargo

ANDA applications rely on an approved product, provided in the FDA’s Orange Book as the Reference Listed Drug (RLD). Approval of the Month: FDA Approves First Closed-Loop Monitoring and Drug Delivery Device. This closed-loop system is the first of its kind and portends future closed-loop systems for other diseases.

article thumbnail

Injectable Drug Delivery 2022

pharmaphorum

Innovations in Formulation and Device Design for Enhanced Subcutaneous Delivery. As Part of Europe’s leading Injectable conference series, we will assess innovations in drug product formulation and biologics, new technologies in device design and the use of long-release injectable compounds. reaching £915 billion by 2027.